XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.728
+0.017 (2.45%)
At close: Mar 6, 2026, 4:00 PM EST
0.759
+0.031 (4.20%)
After-hours: Mar 6, 2026, 6:45 PM EST
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $6.43 million as of March 6, 2026. Its market cap has decreased by -69.73% in one year.
Market Cap
6.43M
Enterprise Value
6.24M
1-Year Change
-69.73%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $6.43M, a decrease of -96.43%. That is a compound annual growth rate of -14.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 6.87M |
| Aptorum Group | 6.73M |
| Aptevo Therapeutics | 6.72M |
| Theriva Biologics | 6.67M |
| Aspire Biopharma Holdings | 6.63M |
| Creative Medical Technology Holdings | 6.50M |
| Immuron | 6.46M |
| Aprea Therapeutics | 6.36M |